Recent Updates
Recently added Catalysts
LMAT Positive Sentiment

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Key Takeaway: LeMaitre Vascular, Inc. will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026. This participation underscores the company's commitment to engaging with investors and highlights its role in the vascular health sector. LeMaitre specializes in devices and services for treating peripheral vascular disease.

Market Sentiment Analysis

POSITIVE FACTORS

  • LeMaitre is actively engaging with investors.
  • Participation in a reputable conference highlights their market presence.
  • Focus on peripheral vascular disease addresses a significant global health issue.

Full Press Release Details

BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Frequently Asked Questions

When is LeMaitre participating in the conference?

LeMaitre will participate in the conference on August 11, 2026.

What is the focus of LeMaitre's products?

LeMaitre specializes in devices for treating peripheral vascular disease.

What type of conference is the Needham event?

It is the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference.

Where can more information about LeMaitre be found?

Additional information is available at www.lemaitre.com.

Last updated: Aug 6, 2026